Author:
Li Zhipeng,Liao Jipei,Yang Zejia,Choi Eun Yong,Lapidus Rena G.,Liu Xuefeng,Cullen Kevin J.,Dan Hancai
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Pendleton, K. P. & Grandis, J. R. Cisplatin-based chemotherapy options for recurrent and/or metastatic squamous cell cancer of the head and neck. Clin. Med. Insights Ther. 5, 103–116 (2013).
2. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 62, 10–29 (2012).
3. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9–22 (2011).
4. Vander Broek, R., Mohan, S., Eytan, D. F., Chen, Z. & Van Waes, C. The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. Oral Dis. 21, 815–825 (2015).
5. Wen, Y. & Grandis, J. R. Emerging drugs for head and neck cancer. Expert. Opin. Emerg. Drugs 20, 313–329 (2015).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献